Comparison of [(18)F]fluciclovine and [(18)F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients

PURPOSE: [(18)F]FDG PET/CT in multiple myeloma (MM) is currently the best technology to demonstrate patchy and extramedullary disease. However, [(18)F]FDG PET has some limitations, and imaging with alternative tracers should be explored. In this study, we aimed to evaluate the performance of [(18)F]...

Descripción completa

Detalles Bibliográficos
Autores principales: Stokke, Caroline, Nørgaard, Jakob Nordberg, Feiring Phillips, Hilde, Sherwani, Alexander, Nuruddin, Syed, Connelly, James, Schjesvold, Fredrik, Revheim, Mona-Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581841/
https://www.ncbi.nlm.nih.gov/pubmed/35501622
http://dx.doi.org/10.1007/s11307-022-01734-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581841/
https://www.ncbi.nlm.nih.gov/pubmed/35501622
http://dx.doi.org/10.1007/s11307-022-01734-0

Ejemplares similares